NCT04655872View on ClinicalTrials.gov

Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 26, 2020

Primary Completion Date

January 27, 2021

Study Completion Date

January 27, 2021

Conditions
Healthy Male Subjects
Interventions
DRUG

[14C]TPN171H

A single 10 mg oral dose of \[14C\]TPN171H containing approximately 100 microcurie of \[14C\]-TPN171H.

Trial Locations (1)

Unknown

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Institute of Materia Medica, Chinese Academy of Sciences

OTHER

lead

Vigonvita Life Sciences

INDUSTRY

NCT04655872 - Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects | Biotech Hunter | Biotech Hunter